Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICAF: Anticoagulants vs Aspirin in Ischemic Stroke with Covert AF
NCT06486792Phase 4Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in ischemic stroke, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2025; status: recruiting.
02
Drugs
apixaban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06486792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06486792.